Trial · NCT02495389
Results by group14
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 14 of 14
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Response to Therapy | Mirabegron | Responded to therapy | 15 | Participants | |
| Response to Therapy | Mirabegron | Did not respond to therapy | 29 | Participants | |
| Change in Overactive Bladder Questionnaire (OAB-q) Health Related Quality of Life (HRQL) | Mirabegron | Baseline | 50.92 | Standard Deviation 26.14 | score on a scale |
| Change in Overactive Bladder Questionnaire (OAB-q) Health Related Quality of Life (HRQL) | Mirabegron | After 12 weeks of therapy | 74.88 | Standard Deviation 25.35 | score on a scale |
| Change in Overactive Bladder Questionnaire (OAB-q) Health Related Quality of Life (HRQL) | Mirabegron | Change Score | 23.96 | Standard Deviation 17.54 | score on a scale |
| Change in Urinary Distress Inventory (UDI) | Mirabegron | Baseline | 121.25 | Standard Deviation 51.19 | score on a scale |
| Change in Urinary Distress Inventory (UDI) | Mirabegron | After 12 weeks of therapy | 69.62 | Standard Deviation 46.75 | score on a scale |
| Change in Urinary Distress Inventory (UDI) | Mirabegron | Change Score | -51.62 | Standard Deviation 40.85 | score on a scale |
| Change in Pelvic Organ Prolapse Distress Inventory (POPDI) Score | Mirabegron | Baseline | 77.85 | Standard Deviation 64.80 | score on a scale |
| Change in Pelvic Organ Prolapse Distress Inventory (POPDI) Score | Mirabegron | After 12 weeks of therapy | 48.55 | Standard Deviation 50.91 | score on a scale |
| Change in Pelvic Organ Prolapse Distress Inventory (POPDI) Score | Mirabegron | Change Score | -29.30 | Standard Deviation 36.28 | score on a scale |
| Change in Colo-Rectal-Anal Distress Inventory (CRADI) | Mirabegron | Baseline | 94.50 | Standard Deviation 82.18 | score on a scale |
| Change in Colo-Rectal-Anal Distress Inventory (CRADI) | Mirabegron | After 12 weeks of therapy | 62.50 | Standard Deviation 68.17 | score on a scale |
| Change in Colo-Rectal-Anal Distress Inventory (CRADI) | Mirabegron | Change Score | -32.00 | Standard Deviation 40.61 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02495389/results